Webinars
Available On Demand
The digital therapeutics (DTx) market is growing rapidly, but a lack of clarity around their reimbursement framework in the U.S. means that there is limited coverage. DTx developers— and pharmaceutical organizations seeking an integrated digital offering— are left to wonder how the payer landscape will evolve as they strategize for the future.
Join Trinity Life Sciences’ MedTech and Evidence, Value, Access and Pricing experts as they explore what the future DTx reimbursement landscape might look like, drawing upon detailed first-hand…
Watch Now
Webinars
Available On Demand
Patient-level insights. Now.
Getting the right therapies to the right patients
Assessing competitive dynamics
Maximizing the value of patient level data with dynamic cohort design and visualization tools
Trinity Patient Flow is an integrated toolkit, built to enable self-serve patient analytics and liberate patient-level data. Any patient-level claims or EHR data can be leveraged–whether it’s internally managed, vendor accessed or pre-populated.
Come join us for a virtual demo and discussion, where Rajeev Rangachari, Head of Product Engineering, Kevin Francis, Partner,…
Watch Now
Webinars
Available On Demand
Developing and refining U.S. contract strategy and contract design is challenging. One of the most critical hurdles is evaluating the holistic direct and indirect impacts of contract decisions across multiple scenarios at speed and with precision. Achieving that comprehensive view drives clear guidance to pricing decision-makers and avoids costly mistakes. Join Monica Martin De Bustamante—Senior Partner & Head of Evidence, Value, Access & Pricing (EVAP), John Greenaway—EVAP Partner and Jennifer Boyce—EVAP Engagement Manager as they discuss tips and Trinity’s best practices to…
Watch Now
Case Studies
Background
A global rare disease company was looking to improve targeting precision and support field team effectiveness
Traditional targeting was non-viable due to the small size of the patient populations, complex disease recognition and diagnosis, and restrictive therapy eligibility criteria
Attempts by a prior analytics partner to use rule-based alerts failed, and even after two years, no new patients had been identified
Given the small number of patients in each indication, every new start is high value, both for the…
Read Now
Blog
Published March 2, 2023
Meet Melissa Leonhauser:
Melissa has over 20 years of experience managing analytic solutions that support pharmaceutical brand teams. She has helped introduce and shape how pharmaceutical manufacturers use Real World Data to understand the patient journey and inform their decision making.
I’m not sure if ‘multi-experience engagements’ is just the newest buzz phrase, but I like it.
It’s similar to ‘omnichannel marketing’ but with a focus on the customer instead of your efforts, and I appreciate that nuance. Let’s break…
Read Now
Blog
Published February 27, 2023
Executive Summary:
The 2023 off-year Drug Price Revisions are the second implementation of the off-year re-pricing approach by the Japanese Ministry of Health, Labor and Welfare (MHLW) and are predicted to result in additional price cuts to 48% of listed products across multiple therapeutic areas.
Although the MHLW continues to maintain a stance of leveraging price revisions to achieve budget savings, other policies (i.e., expansion of Orphan Drug Designation and Price Maintenance Premium revisions) signal an intent to foster and…
Read Now
Webinars
Available On Demand
Healthcare data is complex, voluminous and ever-changing. It can tell you how to attract patients, inform how you look at physicians and signal when the best window is to target them. It can serve many purposes, several concurrently, across life sciences commercialization.
Consequently, a new frontier has emerged: one where leading life sciences companies have moved from discrete projects and workflows into living, related, connected data leveraged across functions and lifecycle stages.
Come join Clare Gora, Vice President and Head…
Watch Now
Briefs
If you have participated in the promotional review process, it can be a delightful, contentious, enlightening or [insert your own adjective here] experience. Some of the brightest minds in the organization gather semi-weekly to provide insight and input on marketing materials that help customers understand the benefits and risks associated with prescribed products.
All participants have an important role in shaping content, and not unlike a game of chess, it can move swiftly, or it can last for months or…
Read Now
White Papers
Gene therapies’ single administration nature presents a unique commercial challenge for biopharmaceutical companies; unlike traditional small molecule or biologic therapies that can be dosed chronically or repeatedly on an “as needed” basis, the one-time per patient administration of a gene therapy means that as time passes, the eligible population decreases in size.
In this white paper, Trinity Life Sciences’ cell and gene therapy experts explore the unique opportunities that life sciences executives can utilize to unlock eligible patient populations and…
Read Now
Briefs
As researchers and clients, we deem the insights of Health Care Professionals (HCP) as being crucial to the development of life saving, game-changing therapies. We require highly skilled, disease-conversant moderators who can match medical terms and treatment protocols with the best of them.
Patient Insights work is vital when it comes to moving the needle toward the creation of ever more efficacious therapeutic options, ultimately leading to better health outcomes. Insights gleaned from patient conversations provide vital end user inputs…
Read Now
